Bio-Rad Laboratories Inc. (BIO)
NYSE · Healthcare
Bio-Rad Laboratories Inc. Operating Income 2008–2025
Bio-Rad Laboratories Inc. annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Bio-Rad Laboratories Inc. operating income for the quarter ending March 31, 2026 was 34.1 M, a 43.88% increase year-over-year.
- Bio-Rad Laboratories Inc. operating income for the twelve months ending March 31, 2026 was 200.2 M, a 33.61% decrease year-over-year.
- Bio-Rad Laboratories Inc. annual operating income for 2025 was 47.2 M, a 82.45% decrease from 2024.
- Bio-Rad Laboratories Inc. annual operating income for 2024 was 269.0 M, a 20.37% decrease from 2023.
- Bio-Rad Laboratories Inc. annual operating income for 2023 was 337.8 M, a 30.00% decrease from 2022.
- Bio-Rad Laboratories Inc. annual operating income for 2022 was 482.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bio-Rad Laboratories Inc. Operating Income — FAQ
Bio-Rad Laboratories Inc. (BIO) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Bio-Rad Laboratories Inc.'s operating income?
Bio-Rad Laboratories Inc. (BIO) reported operating income of $47M for fiscal 2025.
Where can I see BIO's operating income history?
The chart and table above show Bio-Rad Laboratories Inc.'s operating income by year and by quarter, including the growth rate.